Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Plgtm1Dco mutation
(0 available);
any
Plg mutation
(5 available)
Tg(Alb-PLG)1Dgi mutation
(1 available)
|
|
|
mortality/aging
N |
• LPS-treated mice exhibit normal mortality
|
digestive/alimentary system
|
• mice exhibit a near complete rescue of the rectal prolapse observed in Plgtm1Dco homozygotes
|
growth/size/body
|
• mice exhibit a near complete rescue of the decreased body weight observed in Plgtm1Dco homozygotes
|
liver/biliary system
N |
• liver fibrosis observed in Plgtm1Dco homozygotes is reversed
|
Allelic Composition |
Tg(Alb-PLG)1Dgi/0
|
|
Genetic Background |
involves: C57BL/6 * C57BL/6J * SJL |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Alb-PLG)1Dgi mutation
(1 available)
|
|
|
mortality/aging
|
• mice infected subcutaneously with the human pathogenic group A streptococcus (GAS) strain UMAA2616 exhibit 75% of mortality unlike similarly treated wild-type mice that exhibit 20% mortality
• mice infected subcutaneously with GAS strain MGAS166 exhibit 35% to 100% of mortality unlike similarly treated wild-type mice that exhibit 30% mortality
• however, mice exhibit normal mortality when infected with GAS strain UMAA2641, which lacks the Ska gene, or when infected intravenously with UMAA2616
• mice infected subcutaneously with PAM-expressing GAS strain AP53 exhibit 80% mortality compared to 20% in similarly treated wild-type mice
|
immune system
|
• mice infected subcutaneously with the human pathogenic group A streptococcus (GAS) strain UMAA2616 exhibit 75% of mortality unlike similarly treated wild-type mice that exhibit 20% mortality
• mice infected subcutaneously with GAS strain MGAS166 exhibit 35% to 100% of mortality unlike similarly treated wild-type mice that exhibit 30% mortality
• however, mice exhibit normal mortality when infected with GAS strain UMAA2641, which lacks the Ska gene, or when infected intravenously with UMAA2616
• mice infected subcutaneously with PAM-expressing GAS strain AP53 exhibit 80% mortality compared to 20% in similarly treated wild-type mice
• mice infected subcutaneously with GAS exhibit increased bacterial colonies in the spleen compared to similarly infected wild-type mice
|